Microdystrophin Therapy Rescues Impaired Na Currents in Cardiac Purkinje Fibers From Dystrophin-Deficient Mdx Mice.
作者信息
Ebner Janine, Pan Xiufang, Yue Yongping, Sideromenos Spyridon, Marksteiner Jessica, Koenig Xaver, Hilber Karlheinz, Duan Dongsheng
机构信息
Department of Neurophysiology & Neuropharmacology, Center for Physiology & Pharmacology, Medical University of Vienna, Vienna, Austria (J.E., S.S., J.M., X.K., K.H.).
Department of Molecular Microbiology & Immunology (X.P., Y.Y., D.D.).
出版信息
Circ Arrhythm Electrophysiol. 2022 Aug;15(8):e011161. doi: 10.1161/CIRCEP.122.011161. Epub 2022 Aug 2.
Abstract
摘要
相似文献
1
Microdystrophin Therapy Rescues Impaired Na Currents in Cardiac Purkinje Fibers From Dystrophin-Deficient Mdx Mice.
Circ Arrhythm Electrophysiol. 2022 Aug;15(8):e011161. doi: 10.1161/CIRCEP.122.011161. Epub 2022 Aug 2.
2
Reduced Na current in Purkinje fibers explains cardiac conduction defects and arrhythmias in Duchenne muscular dystrophy.
Am J Physiol Heart Circ Physiol. 2020 Jun 1;318(6):H1436-H1440. doi: 10.1152/ajpheart.00224.2020. Epub 2020 May 8.
3
Empagliflozin treatment rescues abnormally reduced Na currents in ventricular cardiomyocytes from dystrophin-deficient mice.
Am J Physiol Heart Circ Physiol. 2024 Feb 1;326(2):H418-H425. doi: 10.1152/ajpheart.00729.2023. Epub 2023 Dec 15.
4
Delivery of AAV2/9-microdystrophin genes incorporating helix 1 of the coiled-coil motif in the C-terminal domain of dystrophin improves muscle pathology and restores the level of α1-syntrophin and α-dystrobrevin in skeletal muscles of mdx mice.
Hum Gene Ther. 2011 Nov;22(11):1379-88. doi: 10.1089/hum.2011.020. Epub 2011 May 25.
5
rAAV6-microdystrophin rescues aberrant Golgi complex organization in mdx skeletal muscles.
Traffic. 2007 Oct;8(10):1424-39. doi: 10.1111/j.1600-0854.2007.00622.x. Epub 2007 Aug 20.
6
Enhancing AAV-microdystrophin gene therapy after repeat dosing by blocking phagocytosis.
Front Immunol. 2025 Mar 3;16:1527840. doi: 10.3389/fimmu.2025.1527840. eCollection 2025.
7
Codon optimization of the microdystrophin gene for Duchene muscular dystrophy gene therapy.
Methods Mol Biol. 2011;709:21-37. doi: 10.1007/978-1-61737-982-6_2.
8
In vitro assay for the efficacy assessment of AAV vectors expressing microdystrophin.
Exp Cell Res. 2020 Jul 15;392(2):112033. doi: 10.1016/j.yexcr.2020.112033. Epub 2020 Apr 29.
9
AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype.
Mol Ther. 2004 Nov;10(5):821-8. doi: 10.1016/j.ymthe.2004.07.025.
10
In Vitro Gene Therapy Using Human iPS-Derived Mesoangioblast-Like Cells (HIDEMs) Combined with Microdystrophin () Expression as the New Strategy for Duchenne Muscular Dystrophy (DMD) Experimental Treatment.
Int J Mol Sci. 2024 Nov 5;25(22):11869. doi: 10.3390/ijms252211869.
引用本文的文献
1
Inhibition of tenascin C rescues abnormally reduced Na currents in dystrophin-deficient ventricular cardiomyocytes.
Am J Physiol Heart Circ Physiol. 2025 Sep 1;329(3):H648-H660. doi: 10.1152/ajpheart.00307.2025. Epub 2025 Aug 11.
2
Conduction defects and arrhythmias in mice are not associated with a degeneration of the cardiac Purkinje network.
Front Physiol. 2025 Jun 26;16:1607916. doi: 10.3389/fphys.2025.1607916. eCollection 2025.
3
Cell size induced bias of current density in hypertrophic cardiomyocytes.
Channels (Austin). 2024 Dec;18(1):2361416. doi: 10.1080/19336950.2024.2361416. Epub 2024 Jun 5.
4
Empagliflozin treatment rescues abnormally reduced Na currents in ventricular cardiomyocytes from dystrophin-deficient mice.
Am J Physiol Heart Circ Physiol. 2024 Feb 1;326(2):H418-H425. doi: 10.1152/ajpheart.00729.2023. Epub 2023 Dec 15.
5
Calcium handling dysfunction and cardiac damage following acute ventricular preload challenge in the dystrophin-deficient mouse heart.
Am J Physiol Heart Circ Physiol. 2023 Nov 1;325(5):H1168-H1177. doi: 10.1152/ajpheart.00265.2023. Epub 2023 Sep 22.
6
Duchenne Muscular Dystrophy Gene Therapy in 2023: Status, Perspective, and Beyond.
Hum Gene Ther. 2023 May;34(9-10):345-349. doi: 10.1089/hum.2023.29242.ddu.
7
Microdystrophin Expression as a Surrogate Endpoint for Duchenne Muscular Dystrophy Clinical Trials.
Hum Gene Ther. 2023 May;34(9-10):404-415. doi: 10.1089/hum.2022.190. Epub 2023 Mar 14.
8
Lifelong Outcomes of Systemic Adeno-Associated Virus Micro-Dystrophin Gene Therapy in a Murine Duchenne Muscular Dystrophy Model.
Hum Gene Ther. 2023 May;34(9-10):449-458. doi: 10.1089/hum.2022.181. Epub 2023 May 2.
9
The Implication of Hinge 1 and Hinge 4 in Micro-Dystrophin Gene Therapy for Duchenne Muscular Dystrophy.
Hum Gene Ther. 2023 May;34(9-10):459-470. doi: 10.1089/hum.2022.180. Epub 2023 Apr 6.
本文引用的文献
1
Duchenne muscular dystrophy.
Nat Rev Dis Primers. 2021 Feb 18;7(1):13. doi: 10.1038/s41572-021-00248-3.
2
Reduced Na current in Purkinje fibers explains cardiac conduction defects and arrhythmias in Duchenne muscular dystrophy.
Am J Physiol Heart Circ Physiol. 2020 Jun 1;318(6):H1436-H1440. doi: 10.1152/ajpheart.00224.2020. Epub 2020 May 8.
3
Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy.
Mol Ther. 2018 Oct 3;26(10):2337-2356. doi: 10.1016/j.ymthe.2018.07.011. Epub 2018 Jul 17.
4
Cardiac-Specific Expression of ΔH2-R15 Mini-Dystrophin Normalized All Electrocardiogram Abnormalities and the End-Diastolic Volume in a 23-Month-Old Mouse Model of Duchenne Dilated Cardiomyopathy.
Hum Gene Ther. 2018 Jul;29(7):737-748. doi: 10.1089/hum.2017.144. Epub 2018 Mar 22.
5
Hierarchical statistical techniques are necessary to draw reliable conclusions from analysis of isolated cardiomyocyte studies.
Cardiovasc Res. 2017 Dec 1;113(14):1743-1752. doi: 10.1093/cvr/cvx151.
Zotero 插件